I joined the Oslo University Hospital in 2022 as Director of the Center for Advanced Cell Therapy (ACT) and also Associate Professor at the University of Oslo. Since 2018, I worked at the Karolinska Institutet as Assistant Professor and Managing Director of the pre-GMP facility in the Department of Laboratory Medicine, where I am still affiliated to this day as research specialist.
I received my Master Degree in Molecular Biotechnology in 2007 from Alma Mater Studiorum Bologna University, Italy. I then moved to the Karolinska Institutet where I received my PhD in 2012. I joined the laboratory of Dr. Steven Rosenberg as post-doctoral fellow at the National Cancer Institute, NIH in 2013 and my research was focused on the isolation of TCR genes from mutation-reactive tumor infiltrating lymphocytes in metastatic solid cancers.
My professional goal is to facilitate and support the development of new immunotherapies against cancer.